Sinopia Biosciences Patents – Insights & Stats (Updated 2023)

Sinopia Biosciences has a total of 33 patents globally, out of which 4 have been granted. Of these 33 patents, more than 90% patents are active. The US is where Sinopia Biosciences has filed the maximum number of patents, followed by China and Japan. Parallelly, the United States seems to be the main focused R&D center of Sinopia Biosciences and is also the origin country of the firm.

Sinopia Biosciences was founded in the year 2014 by Aarash Bordbar and Bernhard Palsson. The company enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

Do read about some of the most popular patents of Sinopia Biosciences which have been covered by us in this article and also you can find Sinopia Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sinopia Biosciences patent portfolio.

How many patents does Sinopia Biosciences have?

Sinopia Biosciences has a total of 33 patents globally. These patents belong to 4 unique patent families. Out of 33 patents, 30 patents are active.

How Many Patents did Sinopia Biosciences File Every Year?

Sinopia Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSinopia Biosciences Applications FiledSinopia Biosciences Patents Granted
202242
202111
20206
201921
20181
20177
2016
2015
2014
2013
2012
2011

How many Sinopia Biosciences patents are Alive/Dead?

Worldwide Patents

Sinopia Biosciences Patent Portfolio

How Many Patents did Sinopia Biosciences File in Different Countries?

Sinopia Biosciences Worldwide Patent Filing

Countries in which Sinopia Biosciences Filed Patents

CountryPatents
United States Of America5
China5
Japan4
Canada3
Australia3
Europe3
Hong Kong (S.A.R.)2
Singapore1
Taiwan1
Korea (South)1
India1
Israel1

Where are Research Centres of Sinopia Biosciences Patents Located?

The R&D Centre of patents filed by Sinopia Biosciences is in the US.

List of Sinopia Biosciences Patents

Sinopia Biosciences PatentsTitle
US11628170B2Treating Extrapyramtdal Syndrome Using Trapidil
US10350212B2Treating Extrapyramidal Syndrome Using Trapidil
US20230201205A1Treating Extrapyramidal Syndrome Using Trapidil
US20230102580A1Isotopically-Labelled Trapidil Derivatives
US20220378794A1Treating Cognitive Disorders Using Trapidil
EP4125853A1Isotopically-Labelled Trapidil Derivatives
EP4069239A1Treating Cognitive Disorders Using Trapidil
EP3442538A4Treating Extrapyramidal Syndrome Using Trapidil
CN116509869ATreatment Of Extrapyramidal Syndrome With Trapidil
CN116496279AIsotope-Labeled Trapidil Derivative
CN115916180AIsotope-Labeled Trapidil Derivative
CN115397425ATreatment Of Cognitive Disorders With Trapidil
CN109310700ATreating Extrapyramidal Syndrome Using Trapidil
JP7049683B2Treatment Of Extrapyramidal Syndrome Using Trapidil
JP2023519289AIsotope-Labeled Trapidil Derivatives
JP2023504004ATreating Cognitive Impairment With Trapidil
JP2022088469ATreatment Of Extrapyramidal Syndrome With Trapidil
AU2017246334C1Treating Extrapyramidal Syndrome Using Trapidil
CA3177066A1Isotopically-Labelled Trapidil Derivatives
CA3163242A1Treating Cognitive Disorders Using Trapidil
CA3054674A1Treating Extrapyramidal Syndrome Using Trapidil
AU2021244241A1Isotopically-Labelled Trapidil Derivatives
AU2020398858A1Treating Cognitive Disorders Using Trapidil
HK40088567AIsotopically-Labelled Trapidil Derivatives
HK40004660ATreating Extrapyramidal Syndrome Using Trapidil
IL296788AIsotopically-Labelled Trapidil Derivatives
IN202217060920AIsotopically-Labelled Trapidil Derivatives
KR1020230013023AIsotopically Labeled Trapidyl Derivatives
SG11202253511VAIsotopically-Labelled Trapidil Derivatives
TW202202502AIsotopically-Labelled Trapidil Derivatives
WO2021195425A1Isotopically-Labelled Trapidil Derivatives
WO2021113266A1Treating Cognitive Disorders Using Trapidil
WO2017176652A3Treating Extrapyramidal Syndrome Using Trapidil

What are Sinopia Biosciences’ key innovation segments?

What Technologies are Covered by Sinopia Biosciences?

The chart below distributes patents filed by Sinopia Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Sinopia Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Sinopia Biosciences’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Sinopia Biosciences?

Related Articles

Computime Patents – Insights & Stats (Updated 2024)

Computime has a total of 224 patents globally, out of which 115 have been granted. Of these 224 patents, more than 63% patents are active. The United States of America is where Computime has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.